Lansdowne Secures £100K Convertible Loan for Legal Fight and Reverse Takeover Push

Right, let’s dive into Lansdowne Oil & Gas’s latest move. Securing another £100k might seem like small beer in the grand scheme of AIM-listed companies, but context is everything here. This isn’t just working capital; it’s gambling chips for a high-stakes legal showdown and a desperate sprint towards corporate survival. Buckle up.

The Lifeline: Convertible Loan Details

Lansdowne has inked a fresh Convertible Loan Agreement for £100,000, arranged by their broker Tavira Financial. This comes hot on the heels of previous loans:

• £95,000 announced in September 2024 (£10,000 of which is still outstanding).
• Bringing the total outstanding Convertible Loan Notes (CLNs) to £230,000.

The terms mirror previous deals – unsecured, zero interest. The real kicker? The conversion mechanics:

• Conversion Trigger: Happens upon completing a reverse takeover (RTO), contingent on shareholder approval for issuing new shares.
• Conversion Price: Lenders get the lower of:
  • 0.1 pence per share (the price when trading was suspended in March 2024), OR
  • A 20% discount to the share price set in the eventual RTO deal.

Essentially, lenders are betting heavily on the RTO happening and are positioning themselves for significant upside, protected by that floor price. It’s a vote of confidence, albeit a high-risk one.

Why This Cash? Two Critical Battlegrounds

Lansdowne isn’t funding day-to-day admin. This £100k is ammunition for two specific, high-cost fronts:

1. The Legal War Chest: Energy Charter Treaty Claim vs. Ireland

Remember the core trauma: In May 2023, the Irish government pulled the plug on the Barryroe field development lease, where Lansdowne held a crucial 20% stake. This wasn’t just a setback; it was existential. Lansdowne retaliated swiftly, initiating arbitration under the Energy Charter Treaty (ECT) in June 2023. ECT claims are complex, lengthy, and eye-wateringly expensive. This cash helps keep that legal challenge alive while they hunt for deeper-pocketed litigation funders. The potential payout if they win could be massive, but it’s a long, costly gamble.

2. The Reverse Takeover (RTO) Sprint

Here’s the other half of their survival strategy. Lansdowne became an AIM Rule 15 cash shell in September 2023, leading to the suspension of its shares in March 2024. The clock is ticking loudly. They must complete a reverse takeover (RTO) to get relisted. Their target? Q3 2025 – that’s imminent in corporate turnaround time. This loan provides vital oxygen to keep negotiating, doing due diligence, and getting the ducks in a row for that crucial RTO deal. Failure isn’t an option here; no RTO means remaining in regulatory purgatory.

The Stakes: Suspension, Shell Status & The Path Back

Let’s be crystal clear about Lansdowne’s current reality:

• Trading Suspended: Shares remain frozen on AIM (since March 2024).
• Cash Shell Status: Limits their operational scope dramatically.
• Only Two Exits:
  • Successfully complete an RTO (publishing an admission doc and getting shareholder approval).
  • Or, less ideally, get readmitted as an investing company (a tougher path requiring £6m+).

The pressure is immense. They’re also finalising their delayed 2024 accounts – another box that must be ticked imminently.

Reading Between the Lines: Confidence & Peril

This £100k loan signals a few things:

1. Shareholder Backing (Selective): Existing and new lenders are still willing to bet, attracted by the conversion terms and the potential jackpot of an RTO or ECT win.
2. Urgency: The targeted Q3 2025 RTO completion is front and centre. This cash is about buying the time needed to cross the finish line.
3. High Wire Act: Lansdowne is burning cash on two incredibly uncertain, expensive endeavours simultaneously. The ECT claim is a legal marathon with an uncertain outcome. Finding and closing a suitable RTO under time pressure is notoriously difficult.

Lansdowne is playing a dangerous, high-stakes game. This £100k is another small lifeline, keeping the lights on for a few more crucial months. The next milestones – publishing those 2024 accounts and, critically, delivering on the promised Q3 RTO – will be make-or-break. Investors are essentially funding a binary outcome: spectacular revival via RTO/legal win, or collapse. The clock is ticking louder than ever.